Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Arrowhead Pharmaceuticals

Clinical trials sponsored by Arrowhead Pharmaceuticals, explained in plain language.

Arrowhead Pharmaceuticals ARWR NASDAQ

Develops RNAi-based therapies for various diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 9 Not yet recruiting 1 Not yet finished but already full! 7 Completed 19 Terminated 11

New shot could help teens with rare, severe high cholesterol

Disease control Not yet recruiting

This study tests a new drug called zodasiran in 12 teens aged 12 to 17 with homozygous familial hypercholesterolemia, a rare genetic condition causing very high cholesterol. The drug is given as a shot under the skin. The main goal is to see if it safely lowers bad cholesterol af…

Phase: PHASE3 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control

Last updated Jun 27, 2026 13:00 UTC